If there is one thing that connects nearly every hallmark of ageing, it is energy. Specifically, the declining ability of cells to produce it efficiently. And that brings us to mitochondria — the organelles responsible for generating the ATP that powers virtually every process in the body, from muscle contraction to DNA repair to immune response.
Mitochondria produce ATP through oxidative phosphorylation — a process that takes place across the inner mitochondrial membrane via the electron transport chain. It is remarkably efficient when things are working properly, generating far more energy per molecule of glucose than anaerobic metabolism can manage. But that efficiency comes with a cost: the electron transport chain generates reactive oxygen species (ROS) as a byproduct.
In a young, healthy cell, ROS are managed by antioxidant defence systems. The damage they cause is repaired faster than it accumulates. But over time, this balance shifts. Mitochondrial DNA — which lacks the protective histones and repair mechanisms that nuclear DNA benefits from — accumulates mutations. The organelles themselves become less efficient, producing less ATP and more ROS per cycle. This creates a feedback loop: damage reduces function, which increases further damage.
The downstream effects of mitochondrial dysfunction are broad and interconnected. Reduced ATP availability means cells have less energy for repair processes, protein synthesis, and active transport. This affects every biological structure in the body, but energy-hungry organs feel it first — the brain, the heart, skeletal muscle, and the liver.
Increased ROS production contributes to oxidative stress, which damages proteins, lipids, and DNA. This is not just theoretical — elevated oxidative markers are consistently observed in ageing biological structures and are associated with virtually every age-related disease state studied.
Mitochondrial dysfunction also triggers inflammatory signalling. Damaged mitochondria release molecular patterns that activate innate immune pathways, contributing to the chronic low-grade inflammation — inflammageing — that characterises older biological systems. This means mitochondrial decline does not just reduce energy; it actively promotes the inflammatory environment that further impairs recovery and biological structure maintenance.
One specific area of research focus is cardiolipin — a phospholipid found exclusively in the inner mitochondrial membrane. Cardiolipin is essential for the proper function of the electron transport chain complexes. It stabilises their structure and facilitates the interactions between them that make oxidative phosphorylation efficient.
With age, cardiolipin content decreases and its composition changes. This directly impacts electron transport chain efficiency and is thought to be a key mechanistic link between ageing and mitochondrial dysfunction. Compounds that stabilise or restore cardiolipin — such as the peptide SS-31 (Elamipretide) — are among the most actively studied in mitochondrial ageing research.
One of the more interesting recent developments is the discovery of mitochondrial-derived peptides (MDPs) — small peptides encoded by mitochondrial DNA that appear to act as signalling molecules. MOTS-c and Humanin are the most studied examples. These peptides seem to communicate the metabolic status of mitochondria to the rest of the cell and to other biological structures, influencing metabolic homeostasis, stress resistance, and inflammation.
Circulating levels of these peptides decline with age, which has led researchers to hypothesise that their loss may contribute to the metabolic dysregulation seen in older populations. MOTS-c in particular has shown promising results in animal studies for improving insulin sensitivity and exercise capacity.
Mitochondrial function is not a single variable — it is a system with multiple potential points of intervention. Researchers are investigating approaches targeting electron transport chain efficiency, ROS management, membrane stability, mitochondrial biogenesis, and the signalling peptides that mitochondria produce. Each represents a different angle on the same fundamental problem: how to maintain cellular energy production in the face of accumulated damage.
Understanding these mechanisms is not just academically interesting. Energy availability determines how well cells can repair, adapt, and respond to stress. It is arguably the most upstream factor in biological ageing, which is precisely why it has become one of the most active areas of peptide and longevity research.
All products referenced are intended for laboratory research use only and are not intended for human consumption.
You must be 21 years or older to access this website. By entering, you confirm that you meet the minimum age requirement.
Sorry, you must be 21 or older to access this site.
For enquiries relating to compound availability, batch data, or technical documentation, please contact: info@revivaxlabs.com
